Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 27Thoracic 21Other solid neoplasm 13Head & Neck 4Tumor-Agnostic 3Lymphoid 3Dermatologic 3Genitourinary 2Other hematologic neoplasm 1Breast 1

Conditions

Recurrence 2Lymphoma, Non-Hodgkin 1Lymphoma, Extranodal NK-T-Cell 1Hodgkin Disease 1

Interventions

Cyclophosphamide 170Rituximab 164Specimen Handling 116Biopsy 92Magnetic Resonance Spectroscopy 90Vincristine 86Doxorubicin 81Prednisone 78fludarabine 70venetoclax 69obinutuzumab 62ibrutinib 55Lenalidomide 55Dexamethasone 55Cytarabine 49Methotrexate 47acalabrutinib 44Etoposide 43CT-P10 42blinatumomab 38fludarabine phosphate 35Bendamustine Hydrochloride 34Gemcitabine 33zanubrutinib 31prednylidene 31pembrolizumab 30glofitamab 30deltacortene 30Calcium Dobesilate 30Nivolumab 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
tislelizumab × Lymphoid × 90 days × Clear all
NCT04539444 2026-06-02

A Study of CD19/22 CART Cells Combined With PD-1 Inhibitor in Relapsed/Refractory B-cell Lymphoma

The First Affiliated Hospital of Soochow University

Phase 2 Completed
18 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Recurrence

NCT07502768 2026-03-31

EpiRev-NKT

Fudan University

Phase 1/2 Not yet recruiting
107 enrolled
Lymphoid

Recurrence, Lymphoma, Extranodal NK-T-Cell

NCT05502250 2026-03-06

HOVON164HL

Stichting Hemato-Oncologie voor Volwassenen Nederland

Phase 2 Active not recruiting
75 enrolled
Lymphoid

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡